Tel.: +33 (0)9 72 56 94 99

Supervisory Board & Investors

Dr Pierre Eftekhari

Dr Pierre Eftekhari

Chairman of the Supervisory Board

Dr Pierre Eftekhari (PhD) is chairman of the Inoviem Scientific Supervisory Board. He is the inventor of Inoviem Scientific technologies and the founder of the company. He is Chief Scientific Officer and President of Inoviem Scientific. He has extensive knowledge of the contract research industry with over 15 years experience in the field. Dr Eftekhari founded several companies prior to founding Inoviem Scientific, and he has been in the management team of Forenap Therapeutics and NewThera.

LEARN MORE

Mr Jean-François Rax

Mr Jean-François Rax

Representative of Alsace Capital

Mr Jean-François Rax is the representative of Alsace Capital. Mr Jean-François Rax has broad experience in Life Sciences company creation and private equity. He has worked for Inserm Transfert, the knowledge transfer subsidiary of Inserm, the French public research institute. He is currently Investment Director at Alsace Capital where he is in charge of the newly created seed fund, Cap Innov’Est.

LEARN MORE

Mr Michel Hubert

Mr Michel Hubert

Independent administrator

Michel HUBERT, President and Founder of NHBP Consulting, has more than 25 years of experience in the pharmaceutical industry. He occupied different corporate and business development positions in major and mid-size pharmaceutical groups and biotech companies such as Abbott Laboratories, Solvay Pharmaceuticals, Novartis, Transgene, Laboratoires Fournier and Rhône-Poulenc (now Sanofi). Pharmacist by training, his career stand out with an impressive track record of deals such as Abbott Fournier Tricor license agreement and related fenofibrate novel formulation deals, Roche Transgene HPV vaccine licensing agreement, Novartis MGH MIT Huntington Disease R&D agreement.

LEARN MORE

Dr Frédéric Perraud

Dr Frédéric Perraud

Invited member of the Supervisory Board

Dr Frédéric Perraud is Chief Financial Officer at Inoviem Scientific. Dr Perraud brings extensive experience in both the Life Sciences and Pharmaceutical industries. Dr Perraud held several top management positions in start-up and established companies. He has been an administrator at Neurofit, a CRO specialised in Neurosciences and had high administrative positions at Carex, a pharmaceutical start-up dedicated to metabolic diseases. Prior to join Inoviem, he was COO and then CEO of Polyplus Transfection, a product company dedicated to the development of transfection reagents for research and clinic.

LEARN MORE

Dr Daniel Da Costa

Dr Daniel Da Costa

Invited member of the Supervisory Board

Dr Daniel Da Costa is Communication and Commercial Officer at Inoviem Scientific. Dr Da Costa holds a PhD in Molecular Biology from the University of Strasbourg, and a Master Innovation Management. Dr Da Costa worked for the Alsatian incubator, Semia, where he worked as Project Manager. He is responsible for the business development of Inoviem Scientific.

LEARN MORE

Investors

Cap Innov’Est is a seed fund, supplied with 36 million euros of assets, investing in innovative projects coming from the three French regions Alsace, Franche-Comté and Burgundy.